Simplifying Global Compliance
FDA Exempts Phase I Drugs From GMPs, Issues Guidance for INDs
Washington Drug Letter
More than two years after withdrawing a final rule that would have exempted investigational drugs in Phase I testing from certain good manufacturing practice (GMP) regulations, the FDA is issuing a final rule to do just that.
To View This Article:
Buy This Article Now
Copyright ©2017. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing